0001104659-22-124100.txt : 20221202
0001104659-22-124100.hdr.sgml : 20221202
20221202161402
ACCESSION NUMBER: 0001104659-22-124100
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221130
FILED AS OF DATE: 20221202
DATE AS OF CHANGE: 20221202
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Jin David
CENTRAL INDEX KEY: 0001930732
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35366
FILM NUMBER: 221442084
MAIL ADDRESS:
STREET 1: C/O AVENUE THERAPEUTICS, INC.
STREET 2: 1140 AVENUE OF THE AMERICAS, FLOOR 9
CITY: NEW YORK
STATE: NY
ZIP: 10036
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Fortress Biotech, Inc.
CENTRAL INDEX KEY: 0001429260
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 205157386
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1111 KANE CONCOURSE
STREET 2: SUITE 301
CITY: BAY HARBOR ISLANDS
STATE: FL
ZIP: 33154
BUSINESS PHONE: 781-652-4500
MAIL ADDRESS:
STREET 1: 1111 KANE CONCOURSE
STREET 2: SUITE 301
CITY: BAY HARBOR ISLANDS
STATE: FL
ZIP: 33154
FORMER COMPANY:
FORMER CONFORMED NAME: CORONADO BIOSCIENCES INC
DATE OF NAME CHANGE: 20080310
4
1
tm2231877-1_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2022-11-30
0
0001429260
Fortress Biotech, Inc.
FBIO
0001930732
Jin David
C/O FORTRESS BIOTECH, INC.
1111 KANE CONCOURSE SUITE 301
BAY HARBOR ISLANDS
FL
33154
0
1
0
0
Chief Financial Officer
COMMON STOCK, PAR VALUE $0.001
2022-11-30
4
P
0
5000
0.56
A
1402829
D
Shares acquired as purchases made under the Issuer's Employee Stock Purchase Plan ("ESPP") during the ESPP offering period. Under the ESPP, 5,000 shares is the maximum amount an individual employee may purchase during an offering period.
The total holdings include 1,350,000 shares underlying restricted stock units.
/s/ David Jin
2022-12-02